Aarti Drugs Buyback 2019 Record Date, Buyback Price & Details

Table of Contents

Aarti Drugs Limited (ADL) established in 1984. They are manufacturer of Pharmaceuticals products. Aarti Drugs has strong presence in the Anti-diarrhea, Anti-inflammatory therapeutic groups. The company has their manufacturing facilities at Tarapur and Sarigam. They manufactures Vitamins, Anti-arthritis, Anti-fungal, Antibiotics, ACE inhibitors, besides its range in , anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs. Their manufacturing units are GMP certified and under process of acquiring an ISO 9002 compliance for all its units and one of the units has already been approved.

Aarti Drugs Buy Back 2019 Offer Details:

 Buyback Record Date:
 Board Meeting Approval:  15-Mar-2019
 Public Announcement:  15-Mar-2019
 Buyback Offer:  Rs.25.389 Crore
 Buyback Offer Size:  5.29%
 Number of Shares:
 Share Face Value:
 Buyback Price:  Rs.900
 Buyback Type:  –

Aarti Drugs buyback of 282100 equity shares which is around 5.29% of all the existing number of equity shares at a price of Rs.900 per equity share. The buyback offer not exceeding of Rs.25.389 crore of total buyback offer size.

Aarti Drugs Buyback Eligible Share Holders:
The investors are eligible of the buyback scheme who have Aarti Drugs shares in their Demat account as record date 29-March-2019. Investors can participate in the Aarti Drugs Buyback 2019 scheme as per the opening form by selling your shares. The payment will be given as per the accepted shares by the company under the Aarti Drugs buyback scheme.

Checkout Current Aarti Drugs Shares market price on NSE and BSE: Aarti Drugs Live Quote

Note: If anything you want to know about the buyback offer you can refer the Aarti Drugs buyback offer documents.

Share the Post:

Follow IPO Watch for the upcoming IPO news and their reviews, also keep following us on TwitterFacebook, and Instagram. For our latest videos, subscribe to our YouTube channel.

2 Responses

Leave a Reply

Your email address will not be published. Required fields are marked *